Track topics on Twitter Track topics that are important to you
Health Care Industry Leaders to Present on 2015 Payment Models and Growth Strategies for a Changing Marketplace Philadelphia, PA (PRWEB) April 06, 2015 Enclara Pharmacia will be hosting What’s Next...
Enclara Pharmacia recognizes that IPUs present a unique challenge for hospices. (PRWEB) May 14, 2015 Widely recognized as the founder, and industry’s leading provider of comprehensive hospice mail ...
Vickie Capps, a member of the boards of Consonance Capital Partners and Enclara Pharmacia, has been tapped to serve on the bo -More-
Enhanced PBM Model Leverages Nationwide Mail Order Fulfillment Capabilities Philadelphia, PA (PRWEB) April 28, 2015 Widely recognized as the founder, and industry’s leading provider of comprehensiv...
New leadership will impact the delivery of the entire Turn-Key Health value proposition: improving quality of life and decreasing expense for patients with advanced illness. Philadelphia, PA (PRWEB) J...
Volker Gelfarth Lieber Leser, Pfizer, gegründet 1849, gehört nach den Übernahmen von Wyeth und Pharmacia zu den weltweit größten Pharma- konzernen. Mit seinen verschreibungspflichtigen Medikament...
About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded...
(MedPage Today) -- Makers of diet drugs spent more than $60 million on payments to doctors, organized medicine, and lobbyists to get their drugs approved.
War on Drugs policing has failed to reduce domestic street-level drug activity: the cost of drugs remains low and drugs remain widely available.
Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced pr...
Three drugs analysed by Prescrire in 2014 provided a significant therapeutic advance for some patients. In 2014, too many drugs are still best avoided, have undergone minimal evaluation, or are excess...
New antimalarial drugs need to be developed because over time resistance against the existing drugs develops. Furthermore, some of the drugs have severe side effects. Here we describe a behavioral sma...
It is becoming more understandable that an existing challenge for translational research is the development of pharmaceuticals that appropriately target reactive oxygen species (ROS)-mediated molecula...